The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides

被引:27
作者
Lubrano, V
Vassalle, C
Blandizzi, C
Del Tacca, M
Palombo, C
L'Abbate, A
Baldi, S
Natali, A
机构
[1] Univ Pisa, Dept Internal Med, I-56100 Pisa, Italy
[2] Univ Pisa, CNR, Inst Clin Physiol, I-56100 Pisa, Italy
[3] Univ Pisa, Div Pharmacol & Chemotherapy, Dept Oncol, I-56100 Pisa, Italy
关键词
endothelial function; nitric oxide; lipoprotein;
D O I
10.1046/j.1365-2362.2003.01083.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim The effect of low-density lipoproteins (LDLs) on endothelial nitric oxide synthase (eNOS) is debated. By coupling in vivo and in vitro experiments we evaluated the role of oxidized lipid substrates in the modulation of eNOS activity by LDLs. Materials and methods Plasma lipids, nitrite/nitrates (NO2 NO3), and malondialdehyde (MDA) were measured in 14 controls, and in 13 patients with familial hypercholesterolemia (FH) before and after 12 weeks of treatment with atorvastatin (20 mg u.i.d.). Nitric oxide synthase in cell lysate and NO2/NO3 into the medium were measured in human microvascular (HMEC-1) and umbilical vein (HUVEC) endothelial cells after 24 h of incubation with increasing concentrations of mildly oxidized LDLs with and without atorvastatin and in HMEC-1 with and without vitamin C. In HMEC-1, NO2/NO3 was also determined after exposure to more intensively oxidized LDLs. Results At baseline, plasma NO2/NO3 (56 +/- 7 vs. 35 +/- 3 muM) and MDA (5.6 +/- 0.7 vs. 2.9 +/- 0.3 muM), were significantly (P < 0.02 for both) higher in the FH patients. In the whole study group, NO2/NO3 was more strongly correlated with plasma MDA (Rho = 0.70) than LDL-cholesterol (Rho = 0.57). In the FH patients, atorvastatin induced a significant decline in plasma total and LDL-cholesterol (-3.1 +/- 0.5 and -2.9 +/- 0.5 mM, respectively), NO2 /NO3 (-35 +/- 8 muM) and MDA (-3.4 +/- 0.7 muM) (P < 0.001 for all). Changes in plasma NO2/NO3 were related to the concomitant changes in plasma MDA (Rho = 0.79, P < 0.006) and not to changes in LDL-cholesterol. In HMEC-1 and in HUVEC, mildly oxidized LDLs stimulated both e-NOS and NO2/NO3 accumulation; the effect on e-NOS was potentiated by vitamin C in HMEC-1. Atorvastatin had no effect in HMEC-1 while it stimulated eNOS but not NO (2) /NO3 in HUVEC. The accumulation of NO2/NO3 in HMEC exposed to increasing concentrations of more intensively oxidized-LDLs showed a nonlinear dose-response curve. Conclusions In uncomplicated patients with FH, plasma NO2/NO3 concentrations are elevated; the cross-sectional data, intervention study and in vitro experiments indicate that oxidized lipids exert a tonic stimulatory action on e-NOS and NO2/NO3 generation not mediated through superoxide anion formation. Atorvastatin amplify this eNOS response in HUVEC, but not in HMEC, and this effect is not associated with a parallel increased NO2 /NO3 generation.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 39 条
[1]   HMEC-1 - ESTABLISHMENT OF AN IMMORTALIZED HUMAN MICROVASCULAR ENDOTHELIAL-CELL LINE [J].
ADES, EW ;
CANDAL, FJ ;
SWERLICK, RA ;
GEORGE, VG ;
SUMMERS, S ;
BOSSE, DC ;
LAWLEY, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (06) :683-690
[2]   NONINVASIVE DETECTION OF EARLY ENDOTHELIAL DYSFUNCTION IN HYPERCHOLESTEROLEMIC SUBJECTS [J].
ARCARO, G ;
ZENERE, BM ;
TRAVIA, D ;
ZENTI, MG ;
COVI, G ;
LECHI, A ;
MUGGEO, M .
ATHEROSCLEROSIS, 1995, 114 (02) :247-254
[3]   Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients [J].
Avogaro, A ;
Piarulli, F ;
Valerio, A ;
Miola, M ;
Calveri, M ;
Pavan, P ;
Vicini, P ;
Cobelli, C ;
Tiengo, A ;
Calo, L ;
DelPrato, S .
DIABETES, 1997, 46 (06) :1040-1046
[4]   NITRIC-OXIDE AND PROSTACYCLIN - DIVERGENCE OF INHIBITORY EFFECTS ON MONOCYTE CHEMOTAXIS AND ADHESION TO ENDOTHELIUM INVITRO [J].
BATH, PMW ;
HASSALL, DG ;
GLADWIN, AM ;
PALMER, RMJ ;
MARTIN, JF .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :254-260
[5]  
BOGER R, 1997, CIRCULATION, V96, P1292
[6]   Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients [J].
Cardillo, C ;
Kilcoyne, CM ;
Cannon, RO ;
Quyyumi, AA ;
Panza, JA .
HYPERTENSION, 1997, 30 (01) :57-63
[7]   THE ROLE OF NITRIC-OXIDE IN ENDOTHELIUM-DEPENDENT VASODILATION OF HYPERCHOLESTEROLEMIC PATIENTS [J].
CASINO, PR ;
KILCOYNE, CM ;
QUYYUMI, AA ;
HOEG, JM ;
PANZA, JA .
CIRCULATION, 1993, 88 (06) :2541-2547
[8]   The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide [J].
Cominacini, L ;
Rigoni, A ;
Fratta Pasini, A ;
Garbin, U ;
Davoli, A ;
Campagnola, R ;
Pastorino, AM ;
Lo Cascio, V ;
Sawamura, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) :13750-13755
[9]  
Dulak J, 1999, J PHYSIOL PHARMACOL, V50, P429
[10]   Neutrophil superoxide anion-generating capacity, endothelial function and oxidative stress in chronic heart failure: Effects of short- and long-term vitamin C therapy [J].
Ellis, GR ;
Anderson, RA ;
Lang, D ;
Blackman, DJ ;
Morris, RHK ;
Morris-Thurgood, J ;
McDowell, IFW ;
Jackson, SK ;
Lewis, MJ ;
Frenneaux, MP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1474-1482